Cat's Claw

Botanical Extract

Cat's claw products may contain Uncaria tomentosa or U. guianensis and differ in oxindole-alkaloid chemotype. Evidence for one standardized extract cannot be generalized to all products.

Pharmacokinetic model

A route-level PK model for cat's claw is being prepared from published data. Dosing references, studies, and documented interactions are below; the app catalog is updated as models are validated.

Key facts

Category
Botanical Extract
Suggested cadence
once daily

Research behind this entry

  1. Randomized double blind trial of an extract from the pentacyclic alkaloid-chemotype of Uncaria tomentosa for the treatment of rheumatoid arthritis Mur E, Hartig F, Eibl G, Schirmer M · Journal of Rheumatology, 2002

    Forty patients received a defined pentacyclic-alkaloid U. tomentosa extract in a two-phase 52-week study. The narrow product and disease context cannot establish generic cat's-claw composition, dosing, or PK.

1 published study referenced in the app, each with a plain-language summary.